WHO Prioritizes Vaccines and Treatments as Ebola Bundibugyo Outbreak Raises Concerns
WHO experts recommend clinical trials for three therapies and several vaccines as the rare Ebola strain has no licensed treatment or prevention options.
- On Thursday, the World Health Organization recommended prioritizing experimental vaccines and treatments for the Bundibugyo Ebola virus strain, currently causing an outbreak in the Democratic Republic of the Congo and Uganda.
- The Bundibugyo virus, which is less common than other Ebola types, presents a significant public health challenge because there are currently no licensed vaccines or treatments specifically approved for this disease.
- Experts identified promising candidates for clinical trials, including the International AIDS Vaccine Initiative's rVSV vaccine, Oxford University's ChAdOx1 vaccine, and Gilead Sciences' antiviral remdesivir alongside monoclonal antibody therapies.
- WHO officials emphasized that all experimental candidates must be evaluated exclusively within clinical trials to ensure safety and ethical standards, while maintaining established containment measures like isolation and contact tracing.
- Vaccine development requires 2 to 3 months for ChAdOx1 and 7 to 9 months for the rVSV candidate, meaning proven public health tools remain the foundation of the response against the spreading virus.
18 Articles
18 Articles
Malay Mail
What Bundibugyo Ebola vaccines and treatments are in the pipeline as Congo outbreak grows
KINSHASA, May 31 — Global health authorities are racing to identify medical options to help contain an Ebola outbreak in eastern Democratic Republic of Congo, linked to the Bundibugyo strain of the virus.Unlike for the more common Zaire strain, there are no approved vaccines or treatments for Bundibugyo.The latest outbreak is suspected to have led to about 906 cases in the Democratic Republic of Congo, including 223 suspected deaths, with the W…
The World Health Organization (WHO) released on Saturday its recommendations on treatments and vaccine candidates that could be used to stem the growing Ebola epidemic in the eastern Democratic Republic of the Congo (DRC). ...
WHO Identifies Potential Ebola Therapies, Vaccines to Test in Outbreak
(MedPage Today) -- On Thursday, the World Health Organization (WHO) said its advisory groups had identified some potential therapies and vaccines to test for Ebola, but recommended they be used exclusively in clinical trials to ensure they are...
Coverage Details
Bias Distribution
- 55% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
